CN108037197B - A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces - Google Patents
A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces Download PDFInfo
- Publication number
- CN108037197B CN108037197B CN201711205106.5A CN201711205106A CN108037197B CN 108037197 B CN108037197 B CN 108037197B CN 201711205106 A CN201711205106 A CN 201711205106A CN 108037197 B CN108037197 B CN 108037197B
- Authority
- CN
- China
- Prior art keywords
- houttuynia cordata
- decoction pieces
- mobile phase
- solution
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000000691 Houttuynia cordata Species 0.000 title claims abstract description 53
- 235000013719 Houttuynia cordata Nutrition 0.000 title claims abstract description 53
- 239000000126 substance Substances 0.000 title claims abstract description 27
- 229930000044 secondary metabolite Natural products 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000004451 qualitative analysis Methods 0.000 title claims description 12
- 238000004445 quantitative analysis Methods 0.000 title claims description 12
- 239000000470 constituent Substances 0.000 title description 3
- 239000013558 reference substance Substances 0.000 claims abstract description 26
- 239000012488 sample solution Substances 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000005516 engineering process Methods 0.000 claims abstract description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019253 formic acid Nutrition 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims abstract description 4
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical group CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 69
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 16
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 15
- 238000013467 fragmentation Methods 0.000 claims description 11
- 238000006062 fragmentation reaction Methods 0.000 claims description 11
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 10
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 9
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 9
- 229940074393 chlorogenic acid Drugs 0.000 claims description 9
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 9
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- MXOKGWUJNGEKBH-UHFFFAOYSA-N aristololactam Chemical compound COC1=CC=CC(C2=C34)=C1C=C3NC(=O)C4=CC1=C2OCO1 MXOKGWUJNGEKBH-UHFFFAOYSA-N 0.000 claims description 7
- 238000004949 mass spectrometry Methods 0.000 claims description 7
- GWTUHAXUUFROTF-UHFFFAOYSA-N pseudochlorogenic acid Natural products C1C(O)C(O)C(O)CC1(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 GWTUHAXUUFROTF-UHFFFAOYSA-N 0.000 claims description 7
- CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 claims description 5
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 claims description 5
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 claims description 5
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 claims description 5
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 claims description 5
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 claims description 5
- KPVDACWQNCRKTG-UHFFFAOYSA-N Aristololactam II Natural products C=1C(C(=O)N2)=C3C2=CC2=CC=CC=C2C3=C2OCOC2=1 KPVDACWQNCRKTG-UHFFFAOYSA-N 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 3
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 claims description 3
- 229940005608 hypericin Drugs 0.000 claims description 3
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000002525 ultrasonication Methods 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 14
- 238000005336 cracking Methods 0.000 abstract description 2
- 238000007781 pre-processing Methods 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 description 34
- 150000001875 compounds Chemical class 0.000 description 22
- 238000001228 spectrum Methods 0.000 description 21
- 229930013930 alkaloid Natural products 0.000 description 15
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- 238000004885 tandem mass spectrometry Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 12
- -1 aglycon radical ion Chemical class 0.000 description 9
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 6
- 150000001793 charged compounds Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 5
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 5
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000007965 phenolic acids Chemical class 0.000 description 5
- GYFFKZTYYAFCTR-UHFFFAOYSA-N 5-O-(6'-O-galloyl)-beta-D-glucopyranosylgentisic acid Natural products OC1CC(O)(C(O)=O)CC(O)C1OC(=O)C=CC1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-UHFFFAOYSA-N 0.000 description 4
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 4
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 4
- CLNINZAIEQRASP-UHFFFAOYSA-N Cannabisin A Chemical compound C1=CC(O)=CC=C1CCNC(=O)C1=CC2=CC(O)=C(O)C=C2C(C=2C=C(O)C(O)=CC=2)=C1C(=O)NCCC1=CC=C(O)C=C1 CLNINZAIEQRASP-UHFFFAOYSA-N 0.000 description 4
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 4
- NBDNEUOVIJYCGZ-CYBMUJFWSA-N R-(-)-asimilobine Chemical compound C([C@H]1NCC2)C3=CC=CC=C3C3=C1C2=CC(O)=C3OC NBDNEUOVIJYCGZ-CYBMUJFWSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- BZKUYNBAFQJRDM-UHFFFAOYSA-N aporphine Chemical compound C12=CC=CC=C2CC2N(C)CCC3=CC=CC1=C32 BZKUYNBAFQJRDM-UHFFFAOYSA-N 0.000 description 4
- NBDNEUOVIJYCGZ-UHFFFAOYSA-N asimilobine Natural products C1CNC2CC3=CC=CC=C3C3=C2C1=CC(O)=C3OC NBDNEUOVIJYCGZ-UHFFFAOYSA-N 0.000 description 4
- YHQIYHDLBZXUON-UHFFFAOYSA-N cepharanone b Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)N4)=C3C4=CC2=C1 YHQIYHDLBZXUON-UHFFFAOYSA-N 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- GYFFKZTYYAFCTR-LMRQPLJMSA-N cryptochlorogenic acid Natural products O[C@H]1C[C@@](O)(C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O GYFFKZTYYAFCTR-LMRQPLJMSA-N 0.000 description 4
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 235000009048 phenolic acids Nutrition 0.000 description 4
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 4
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- GYFFKZTYYAFCTR-AVXJPILUSA-N (3r,5r)-4-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,3,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-AVXJPILUSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000008441 aporphines Chemical class 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 3
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 3
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical group O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 2
- KTFPZTCBZNFIPH-UHFFFAOYSA-N 1,2,4-trimethoxy-7h-dibenzo[de,g]quinolin-7-one Chemical compound O=C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C(OC)C=NC1=C32 KTFPZTCBZNFIPH-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- GVVXPMORGFYVOO-ZDUSSCGKSA-N Laurotetanine Chemical compound N1CCC2=CC(OC)=C(OC)C3=C2[C@@H]1CC1=C3C=C(OC)C(O)=C1 GVVXPMORGFYVOO-ZDUSSCGKSA-N 0.000 description 2
- NPNNKDMSXVRADT-WEVVVXLNSA-N N-feruloyltyramine Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)NCCC=2C=CC(O)=CC=2)=C1 NPNNKDMSXVRADT-WEVVVXLNSA-N 0.000 description 2
- QCMQEZNBBPGFKQ-UHFFFAOYSA-N Thalisopynine Natural products CN1CCC2=C(OC)C(OC)=C(OC)C3=C2C1CC1=C3C=C(OC)C(O)=C1 QCMQEZNBBPGFKQ-UHFFFAOYSA-N 0.000 description 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 2
- SOSLMHZOJATCCP-AEIZVZFYSA-N afzelin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O SOSLMHZOJATCCP-AEIZVZFYSA-N 0.000 description 2
- 229930187117 aristolactam Natural products 0.000 description 2
- OWHIYNVJYMRDOV-GFCCVEGCSA-N aristolactam BII Natural products COc1cc2C(=O)N[C@@H]3Cc4ccccc4c(c1OC)c23 OWHIYNVJYMRDOV-GFCCVEGCSA-N 0.000 description 2
- 239000012490 blank solution Substances 0.000 description 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 2
- 229950011318 cannabidiol Drugs 0.000 description 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- NPNNKDMSXVRADT-UHFFFAOYSA-N cis-N-feruloyl tyramine Natural products C1=C(O)C(OC)=CC(C=CC(=O)NCCC=2C=CC(O)=CC=2)=C1 NPNNKDMSXVRADT-UHFFFAOYSA-N 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 2
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- FVRABHGHBLRNNR-UHFFFAOYSA-N liriodenine Natural products O=C1C=CC=c2c1cc3nccc4cc5OCOc5c2c34 FVRABHGHBLRNNR-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- BAGGDUOPTSQTHD-UHFFFAOYSA-N norcepharadione b Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=CC2=C1 BAGGDUOPTSQTHD-UHFFFAOYSA-N 0.000 description 2
- MSQSEOYPHJGUTP-UHFFFAOYSA-N ouregidione Chemical compound C1=CC=C2C3=C(OC)C(OC)=C(OC)C(C(=O)C(=O)N4)=C3C4=CC2=C1 MSQSEOYPHJGUTP-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- MWDVCHRYCKXEBY-LBPRGKRZSA-N 3-chloro-n-[2-oxo-2-[[(1s)-1-phenylethyl]amino]ethyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(Cl)=C1 MWDVCHRYCKXEBY-LBPRGKRZSA-N 0.000 description 1
- GYFFKZTYYAFCTR-JUHZACGLSA-N 4-O-trans-caffeoylquinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-JUHZACGLSA-N 0.000 description 1
- 241000726094 Aristolochia Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- DBNFUUYMTAGFDM-UHFFFAOYSA-N Cepharadione B Natural products C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=C(Cl)C2=C1 DBNFUUYMTAGFDM-UHFFFAOYSA-N 0.000 description 1
- AFKGBLKLNRDQFN-UHFFFAOYSA-N Cepharadione B Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4C)=C3C4=CC2=C1 AFKGBLKLNRDQFN-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- DPBMWJXWUINLQT-UHFFFAOYSA-N Lysicamine Chemical compound O=C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=CC=NC1=C32 DPBMWJXWUINLQT-UHFFFAOYSA-N 0.000 description 1
- CTCKPFXFWVNGLG-UHFFFAOYSA-N Megastigmenetetrol Natural products CC(O)C=CC1(O)C(C)(C)CC(O)CC1(C)O CTCKPFXFWVNGLG-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 108010080154 N-benzoylphenylalanylphenylalinol acetate Proteins 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- VZPAURMDJZOGHU-DQEYMECFSA-N [(2s)-2-[[(2s)-2-benzamido-3-phenylpropanoyl]amino]-3-phenylpropyl] acetate Chemical compound C([C@@H](COC(=O)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)C=1C=CC=CC=1)C1=CC=CC=C1 VZPAURMDJZOGHU-DQEYMECFSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- VZPAURMDJZOGHU-JWQCQUIFSA-N asperglaucide Natural products CC(=O)OC[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)c1ccccc1 VZPAURMDJZOGHU-JWQCQUIFSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- ZPFKRQXYKULZKP-UHFFFAOYSA-N butylidene Chemical group [CH2+]CC[CH-] ZPFKRQXYKULZKP-UHFFFAOYSA-N 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- GVVXPMORGFYVOO-UHFFFAOYSA-N dl-Laurotetanine Natural products N1CCC2=CC(OC)=C(OC)C3=C2C1CC1=C3C=C(OC)C(O)=C1 GVVXPMORGFYVOO-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- WKURQIYEQPIIIA-UHFFFAOYSA-N lysicamine Natural products COc1cc2CCN=C3C(=O)c4ccccc4c(c1OC)c23 WKURQIYEQPIIIA-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical group OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
技术领域technical field
本发明涉及中药材制剂化学成分检测技术领域,特别涉及一种鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析的方法。The invention relates to the technical field of detection of chemical components of traditional Chinese medicinal material preparations, in particular to a method for qualitative and quantitative analysis of chemical components of non-volatile secondary metabolites of Houttuynia cordata decoction pieces.
背景技术Background technique
鱼腥草破壁饮片是以鱼腥草为原料利用中药破壁技术制成的破壁饮片产品。鱼腥草为三白草科植物蕺菜(Houttuynia cordata Thunb.)的干燥地上部分,具有清热解毒、消痈排脓、利尿通淋的功效,中医主要用于肺痈吐脓、痰热喘咳、热痢、热淋、痈肿疮毒等病症。中药破壁饮片是将符合法定标准要求并具有细胞结构的植物类中药饮片,经现代粉碎技术加工至D90﹤45μm(300目以上)的粉体,通过诱发自身物质的粘合性,制成30~100目的原饮片全成分的均匀干燥颗粒状饮片。相比传统饮片,中药破壁饮片具有质量均一,药物利用率高、稳定性好及应用方便快捷的优势。但是,由于中药破壁饮片不具传统中药饮片的形态特征,破壁后会带来有效成分或指标成分等化学成分的变化;因此破壁饮片产品的成分分析具有重要的意义。Houttuynia cordata broken wall decoction piece is a broken wall decoction piece product made from Houttuynia cordata using traditional Chinese medicine wall breaking technology. Houttuynia cordata is the dry aerial part of Houttuynia cordata Thunb. , heat dysentery, hot stranguria, carbuncle sore and other diseases. Chinese herbal broken wall decoction pieces are plant Chinese medicine decoction pieces that meet the requirements of legal standards and have a cellular structure, and are processed to D90﹤45μm (above 300 mesh) powder by modern pulverization technology. ~100-mesh homogeneous dry granular decoction pieces with all the ingredients of the original decoction pieces. Compared with traditional decoction pieces, broken wall decoction pieces of traditional Chinese medicine have the advantages of uniform quality, high drug utilization rate, good stability and convenient and quick application. However, because the broken wall decoction pieces of traditional Chinese medicine do not have the morphological characteristics of traditional Chinese medicine decoction pieces, the broken wall will bring changes in chemical components such as active ingredients or index components; therefore, the composition analysis of broken wall decoction pieces is of great significance.
鱼腥草的化学成分主要包括挥发油、酚酸类、黄酮类及生物碱类等化合物,目前挥发油类成分主要采用GC-MS进行检测,而对于非挥发性次生代谢产物(酚酸类、黄酮类及生物碱类等化合物)的研究,现有技术还主要集中在提取、分离和鉴定方面,不能够全面反映鱼腥草的化学物质基础,也难以反映出不同产地鱼腥草有效成分的多样性差别和特征性。同时现有技术中对鱼腥草破壁饮片化学成分的研究还未见报道。The chemical components of Houttuynia cordata mainly include volatile oils, phenolic acids, flavonoids and alkaloids. Compounds such as alkaloids and alkaloids), the existing technology also mainly focuses on extraction, separation and identification, which cannot fully reflect the chemical substance basis of Houttuynia cordata, and it is difficult to reflect the diversity of Houttuynia cordata active ingredients in different origins. Sexual differences and characteristics. At the same time, there is no report on the research on the chemical constituents of Houttuynia cordata broken wall decoction pieces in the prior art.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于克服现有技术中鱼腥草破壁饮片中非挥发性次生代谢产物成分分析检测技术的缺陷和不足,提供一种鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析的方法。本发明提供的方法首次利用UHPLC-Q-TOF/MS技术,通过特定流动相的选取,实现了对鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析,具有速度快、专属性强、检测限低、定性和定量能力强等优点。The purpose of the present invention is to overcome the defects and deficiencies of the non-volatile secondary metabolite component analysis and detection technology in the Houttuynia cordata wall-broken pieces in the prior art, and to provide a non-volatile secondary metabolite chemical composition of the Houttuynia cordata broken-wall pieces. Methods of qualitative and quantitative analysis. The method provided by the invention utilizes UHPLC-Q-TOF/MS technology for the first time, and realizes the qualitative and quantitative analysis of the chemical components of non-volatile secondary metabolites of Houttuynia cordata broken wall decoction pieces through the selection of a specific mobile phase. It has the advantages of strong specificity, low detection limit, strong qualitative and quantitative ability and so on.
为实现上述发明目的,本发明采用如下技术方案:For realizing the above-mentioned purpose of the invention, the present invention adopts following technical scheme:
一种鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析的方法,所述检测方法包括如下步骤:A method for qualitative and quantitative analysis of chemical components of non-volatile secondary metabolites of Houttuynia cordata decoction pieces, the detection method comprises the following steps:
S1:将鱼腥草破壁饮片预处理制成样品溶液;S1: Pretreatment of the broken pieces of Houttuynia cordata to make a sample solution;
S2:运用UHPLC-Q-TOF/MS技术,以对照品为对照和裂解碎片信息与相关数据库进行比对,对样品中的非挥发类次生代谢产物化学成分进行定性或定量分析,其中流动相A为甲酸水溶液,流动相B为甲酸乙腈溶液。S2: Using UHPLC-Q-TOF/MS technology, using the reference substance as a control and comparing the fragmentation information with the relevant database, qualitative or quantitative analysis of the chemical components of non-volatile secondary metabolites in the sample is carried out. A is formic acid aqueous solution, and mobile phase B is formic acid acetonitrile solution.
本发明首次利用UHPLC-Q-TOF/MS技术,通过特定流动相的选取,实现了对鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量的分析,共检测出酚酸类、黄酮类及生物碱类等非挥发性次生代谢产物36种,具有速度快、专属性强、检测限低、定性和定量能力强等优点。The present invention utilizes UHPLC-Q-TOF/MS technology for the first time and realizes the qualitative and quantitative analysis of the chemical components of the non-volatile secondary metabolites of the broken pieces of Houttuynia cordata through the selection of a specific mobile phase, and a total of phenolic acids are detected. 36 kinds of non-volatile secondary metabolites, such as flavonoids and alkaloids, have the advantages of fast speed, strong specificity, low detection limit, strong qualitative and quantitative ability and so on.
优选地,所述梯度洗脱条件为:0.0~12.0min:流动相A:90%→65%;12.0~23.0min:流动相A:65%→5%;23.0~26.0min:流动相A:5%;26.0~27.0min:流动相A:5%→90%。Preferably, the gradient elution conditions are: 0.0-12.0min: mobile phase A: 90%→65%; 12.0-23.0min: mobile phase A: 65%→5%; 23.0-26.0min: mobile phase A: 5%; 26.0~27.0min: mobile phase A: 5%→90%.
优选地,所述流动相A和B中甲酸的体积分数为0.1%。Preferably, the volume fraction of formic acid in the mobile phases A and B is 0.1%.
优选地,所述S1的样品溶液中鱼腥草破壁饮片的质量浓度为10~30mg/mL。更为优选地,所述S1的样品溶液中鱼腥草破壁饮片的质量浓度为20mg/mL。Preferably, the mass concentration of the broken pieces of Houttuynia cordata in the sample solution of S1 is 10-30 mg/mL. More preferably, the mass concentration of Houttuynia cordata broken wall decoction pieces in the sample solution of S1 is 20 mg/mL.
本发明所选用的对照品为现有技术中常用的对照品溶液,可直接购买得到。The selected reference substance in the present invention is the reference substance solution commonly used in the prior art, which can be directly purchased.
优选地,所述对照品为绿原酸、新绿原酸、槲皮苷、金丝桃苷、大麻酰胺或马兜铃内酰胺I一种或数种混合甲醇溶液。Preferably, the reference substance is one or more mixed methanol solutions of chlorogenic acid, neochlorogenic acid, quercitrin, hypericin, cannabidiolamide or aristololactam I.
优选地,所述对照品中绿原酸的浓度为5.00~50.00μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中绿原酸的浓度为5.00μg/ml、10.00μg/ml、20.00μg/ml、30.00μg/ml、40.00μg/ml和50.00μg/ml。Preferably, the concentration of chlorogenic acid in the reference substance is at least 5 concentration values within the concentration range of 5.00-50.00 μg/ml. More preferably, the concentration of chlorogenic acid in the reference substance is 5.00 μg/ml, 10.00 μg/ml, 20.00 μg/ml, 30.00 μg/ml, 40.00 μg/ml and 50.00 μg/ml.
优选地,所述对照品中新绿原酸的浓度为6.00~48.00μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中新绿原酸的浓度为6.00μg/ml、12.00μg/ml、24.00μg/ml、36.00μg/ml和48.00μg/ml。Preferably, the concentration of neochlorogenic acid in the reference substance is at least 5 concentration values within the concentration range of 6.00-48.00 μg/ml. More preferably, the concentration of neochlorogenic acid in the control substance is 6.00 μg/ml, 12.00 μg/ml, 24.00 μg/ml, 36.00 μg/ml and 48.00 μg/ml.
优选地,所述对照品中槲皮苷的浓度为32.40~97.20μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中槲皮苷的浓度为32.40μg/ml、48.60μg/ml、64.80μg/ml、81.00μg/ml和97.20μg/ml。Preferably, the concentration of quercetin in the reference substance is at least 5 concentration values within the concentration range of 32.40-97.20 μg/ml. More preferably, the concentration of quercitrin in the control substance is 32.40 μg/ml, 48.60 μg/ml, 64.80 μg/ml, 81.00 μg/ml and 97.20 μg/ml.
优选地,所述对照品中金丝桃苷的浓度为4.00~40.00μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中绿原酸的浓度为4.00μg/ml、8.00μg/ml、16.00μg/ml、24.00μg/ml、32.00μg/ml和40.00μg/ml。Preferably, the concentration of hyperin in the reference substance is at least 5 concentration values within the concentration range of 4.00-40.00 μg/ml. More preferably, the concentration of chlorogenic acid in the reference substance is 4.00 μg/ml, 8.00 μg/ml, 16.00 μg/ml, 24.00 μg/ml, 32.00 μg/ml and 40.00 μg/ml.
优选地,所述对照品中马兜铃内酰胺I的浓度为1.84~9.20μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中槲皮苷的浓度为1.84μg/ml、3.68μg/ml、5.52μg/ml、7.36μg/ml和9.20μg/ml。Preferably, the concentration of aristololactam I in the reference substance is at least 5 concentration values within the concentration range of 1.84-9.20 μg/ml. More preferably, the concentration of quercetin in the control substance is 1.84 μg/ml, 3.68 μg/ml, 5.52 μg/ml, 7.36 μg/ml and 9.20 μg/ml.
优选地,所述对照品中大麻酰胺(CannabisinA)的浓度为0.80~16.08μg/ml浓度范围内的至少5个浓度值。更为优选地,所述对照品中大麻酰胺的浓度为0.80μg/ml、1.61μg/ml、4.02μg/ml、8.04μg/ml和16.08μg/ml。Preferably, the concentration of cannabisin A in the reference substance is at least 5 concentration values within the concentration range of 0.80-16.08 μg/ml. More preferably, the concentration of cannabidiol in the control substance is 0.80 μg/ml, 1.61 μg/ml, 4.02 μg/ml, 8.04 μg/ml and 16.08 μg/ml.
优选地,色谱柱为Agilent Eclips Plus C18,流速为0.3mL/min,柱温为25℃,进样量为2μL。Preferably, the chromatographic column is Agilent Eclips Plus C18, the flow rate is 0.3 mL/min, the column temperature is 25°C, and the injection volume is 2 μL.
优选地,质谱条件为:气体温度:200℃;毛细管电压:4500v(+),3500v(-);端平台偏移:500;干燥气流速:8L/min;喷雾气压力:2.5Bar;采集速率:2.0HZ;驻留时间:3.5sec;响应绝对阈值:213cts;扫描范围:50~1300m/z。Preferably, the mass spectrometry conditions are: gas temperature: 200°C; capillary voltage: 4500v(+), 3500v(-); end platform offset: 500; drying gas flow rate: 8L/min; spray gas pressure: 2.5Bar; acquisition rate : 2.0HZ; dwell time: 3.5sec; response absolute threshold: 213cts; scanning range: 50~1300m/z.
本发明还提供一种高效提取方法来制备含鱼腥草破壁饮片的样品溶液。The invention also provides an efficient extraction method for preparing a sample solution containing broken wall decoction pieces of Houttuynia cordata.
优选地,S1中样品溶液通过如下方法制备得到:将鱼腥草破壁饮片粉碎后溶解于甲醇溶液中提取,超声、离心、过滤取上清液稀释即得所述样品溶液,所述甲醇溶液中甲醇的质量分数为50~100%。Preferably, the sample solution in S1 is prepared by the following method: the broken pieces of Houttuynia cordata are crushed and dissolved in methanol solution for extraction, ultrasonication, centrifugation and filtration to take the supernatant to dilute to obtain the sample solution, the methanol solution The mass fraction of methanol is 50-100%.
优选地,所述甲醇溶液中甲醇的质量分数为70%。Preferably, the mass fraction of methanol in the methanol solution is 70%.
优选地,所述鱼腥草破壁饮片的提取次数为2次。Preferably, the number of times of extraction of the Houttuynia cordata broken wall decoction pieces is 2 times.
优选地,所述鱼腥草破壁饮片和甲醇溶液的用量为50mg:1mL。Preferably, the dosage of Houttuynia cordata broken wall decoction pieces and methanol solution is 50mg:1mL.
优选地,所述超声条件为:超声频率:50~60kHz,超声时间:30分钟;所述离心条件为:转速:4500转/分钟,离心时间:5分钟。Preferably, the ultrasonic conditions are: ultrasonic frequency: 50-60 kHz, ultrasonic time: 30 minutes; the centrifugation conditions are: rotational speed: 4500 rpm, and centrifugation time: 5 minutes.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明提供的鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析的方法通过运用UHPLC-Q-TOF/MS技术,可鉴定鱼腥草及鱼腥草破壁饮片中非挥发性次生代谢产物成分种类并进行定量分析,共检测出酚酸类、黄酮类及生物碱类等非挥发性次生代谢产物36种,具有速度快、专属性强、检测限低、定性和定量能力强等优点,可应用于产地鱼腥草有效成分的多样性差别和特征性分析中。The method for qualitative and quantitative analysis of the chemical components of non-volatile secondary metabolites in Houttuynia cordata broken wall decoction pieces provided by the present invention can identify non-volatile Houttuynia cordata and Houttuynia cordata broken wall decoction pieces by using UHPLC-Q-TOF/MS technology. The components of volatile secondary metabolites were quantitatively analyzed, and a total of 36 non-volatile secondary metabolites such as phenolic acids, flavonoids and alkaloids were detected. It has the advantages of strong quantitative ability, etc., and can be applied to the diversity difference and characteristic analysis of the active components of Houttuynia cordata in the producing area.
附图说明Description of drawings
图1为实施例1(50%甲醇)、实施例2(70%甲醇)和实施例3(100%甲醇)对鱼腥草破壁饮片提取效率的考察;Fig. 1 is the investigation of embodiment 1 (50% methanol), embodiment 2 (70% methanol) and embodiment 3 (100% methanol) on the extraction efficiency of Houttuynia cordata broken wall decoction pieces;
图2为实施例2提供的检测方法得到的样品溶液和空白溶液的正离子模式下BPC图谱;Fig. 2 is the BPC spectrum under the positive ion mode of the sample solution that the detection method provided by
图3为实施例2提供的检测方法得到的样品溶液和空白溶液的负离子模式下BPC图谱;Fig. 3 is the BPC spectrum under the negative ion mode of the sample solution that the detection method that
图4为鱼腥草饮片260~400nm紫外吸收图;Figure 4 is the UV absorption diagram of Houttuynia cordata decoction pieces at 260-400 nm;
图5为绿原酸类成分的正离子模式MS/MS图谱;Figure 5 is the positive ion mode MS/MS spectrum of chlorogenic acids;
图6为负离子模式下化合物1(5-CQA)、2(3-CQA)、3(4-CQA)的MS/MS图谱;Fig. 6 is the MS/MS spectrum of compound 1 (5-CQA), 2 (3-CQA), 3 (4-CQA) under negative ion mode;
图7为负离子模式下化合物17Quercetin的MS/MS图谱;Figure 7 is the MS/MS spectrum of compound 17Quercetin in negative ion mode;
图8为负离子模式下黄酮类化合物Rutin、Vitexin和Afzelin的MS/MS图谱;Figure 8 is the MS/MS spectrum of the flavonoids Rutin, Vitexin and Afzelin in negative ion mode;
图9为鱼腥草破壁饮片及对照品Hyperoside负离子模式下出峰时间对比图;Fig. 9 is a comparison chart of the peak time of Houttuynia cordata broken wall decoction pieces and the reference substance Hyperoside negative ion mode;
图10为鱼腥草中生物碱类成分分类示意图;Figure 10 is a schematic diagram of the classification of alkaloids in Houttuynia cordata;
图11Amides类生物碱正离子模式下二级质谱碎片图;Figure 11. Fragmentation map of secondary mass spectrometry in positive ion mode of Amides alkaloids;
图12为马兜铃内酰胺类化合物20、20’、23和25在正离子模式下的二级质谱图;Figure 12 is the secondary mass spectrum of aristololactam compounds 20, 20', 23 and 25 in positive ion mode;
图13为化合物9正离子模式下的MS/MS图谱;Figure 13 is the MS/MS spectrum of compound 9 in positive ion mode;
图14为Massbank中正离子模式下巴婆碱(Asimilobine)的ESI-MS/MS图谱及其结构式。Figure 14 shows the ESI-MS/MS spectrum and structural formula of Asimilobine in Massbank in positive ion mode.
具体实施方式Detailed ways
下面结合实施例进一步阐述本发明。这些实施例仅用于说明本发明而不用于限制本发明的范围。下例实施例中未注明具体条件的实验方法,通常按照本领域常规条件或按照制造厂商建议的条件;所使用的原料、试剂等,如无特殊说明,均为可从常规市场等商业途径得到的原料和试剂。本领域的技术人员在本发明的基础上所做的任何非实质性的变化及替换均属于本发明所要求保护的范围。The present invention is further described below in conjunction with the examples. These examples are only intended to illustrate the present invention and not to limit the scope of the present invention. The experimental methods that do not specify specific conditions in the following examples are usually in accordance with the conventional conditions in the field or the conditions suggested by the manufacturer; the raw materials, reagents, etc. used, unless otherwise specified, are available from commercial channels such as conventional markets. The obtained raw materials and reagents. Any insubstantial changes and substitutions made by those skilled in the art on the basis of the present invention fall within the scope of protection claimed by the present invention.
实施例1~3鱼腥草破壁饮片非挥发类次生代谢产物化学成分的定性及定量分析的方法Embodiments 1-3 Methods for qualitative and quantitative analysis of the chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces
1、一种鱼腥草破壁饮片非挥发类次生代谢产物化学成分定性及定量分析的方法,包括如下步骤:1. A method for qualitative and quantitative analysis of chemical components of non-volatile secondary metabolites of Houttuynia cordata decoction pieces, comprising the following steps:
(1)将鱼腥草破壁饮片预处理制成样品溶液;(1) pretreatment of the broken wall decoction pieces of Houttuynia cordata is made into sample solution;
取3批鱼腥草破壁饮片等量,混合均匀,粉碎过2号筛,精密称量0.5g粉末3份,分别加入50%甲醇、70%甲醇、100%甲醇各10mL,超声处理(功率:220W,频率:50-60kHz)30分钟,4500转/分钟离心5分钟,取上清液;再按相同的方法将滤渣再提取1次,分别合并上清液;将3份上清液定容至25mL量瓶,摇匀,滤过,取续滤液,即分别为实施例1、2和3的含鱼腥草破壁饮片的样品溶液。Take 3 batches of Houttuynia cordata broken wall decoction pieces, mix them evenly, smash through No. 2 sieve, accurately weigh 3 parts of 0.5g powder, add 50% methanol, 70% methanol, 100% methanol each 10mL, ultrasonic treatment (power : 220W, frequency: 50-60kHz) for 30 minutes, centrifuge at 4500 rpm for 5 minutes, and take the supernatant; then extract the filter residue once again in the same way, and combine the supernatants separately; Fill the volume to a 25mL volumetric flask, shake well, filter, and take the subsequent filtrate, which is the sample solution containing the broken-wall decoction pieces of Houttuynia cordata of Examples 1, 2 and 3, respectively.
(2)运用UHPLC-Q-TOF/MS技术,以对照品为对照和裂解碎片信息与相关数据库进行比对,对样品中的非挥发类次生代谢产物化学成分进行定性或定量分析,其中流动相A为甲酸水溶液,流动相B为甲酸乙腈溶液。(2) Using UHPLC-Q-TOF/MS technology, using the reference substance as a control and comparing the fragmentation information with the relevant database, qualitative or quantitative analysis of the chemical components of non-volatile secondary metabolites in the sample was carried out. Phase A is formic acid in water and mobile phase B is formic acid in acetonitrile.
称取绿原酸、新绿原酸、槲皮苷、金丝桃苷、马兜铃内酰胺I对照品(厂家:成都瑞芬思生物科技有限公司,纯度>96%)、大麻酰胺(自制,纯度>96%)适量,加甲醇制成如表1所示浓度的混合对照品溶液。Weigh chlorogenic acid, neochlorogenic acid, quercitrin, hypericin, aristololactam I reference substance (manufacturer: Chengdu Refensi Biotechnology Co., Ltd., purity> 96%), cannabidiol (self-made, Purity>96%) appropriate amount, add methanol to make the mixed reference solution with the concentration shown in Table 1.
表1对照品系列浓度Table 1 Concentration of reference substance series
(3)分析条件(3) Analysis conditions
选用仪器:Agilent 1290series UHPLC,Bruker Q-TOF MS,色谱柱:AgilentEclips Plus C18(2.1×150mm,1.8μm),控制流速:0.3ml/min,柱溫:25℃,进样量:2μl;并选用如表2所示的色谱条件和表3所示的质谱条件。Selected instrument: Agilent 1290series UHPLC, Bruker Q-TOF MS, chromatographic column: AgilentEclips Plus C18 (2.1×150mm, 1.8μm), control flow rate: 0.3ml/min, column temperature: 25°C, injection volume: 2μl; Chromatographic conditions shown in Table 2 and mass spectrometry conditions shown in Table 3.
表2梯度洗脱条件Table 2 Gradient elution conditions
表3质谱条件Table 3 Mass Spectrometry Conditions
2、测定结果2. Measurement results
如图1所示,为实施例1~3采用不同提取方式对鱼腥草破壁饮片提取效率的考察。从图可知,50~100%的甲醇溶液均可将鱼腥草破壁饮片中非挥发类次生代谢产物提取出来。As shown in Figure 1, it is the investigation of the extraction efficiency of Houttuynia cordata broken wall decoction pieces using different extraction methods in Examples 1-3. It can be seen from the figure that 50-100% methanol solution can extract the non-volatile secondary metabolites in the broken pieces of Houttuynia cordata.
2.1非挥发性次生代谢产物的成分鉴定2.1 Component identification of nonvolatile secondary metabolites
选用实施例2提供的检测方法(即甲醇溶液浓度为70%,提取两次)进行检测。如图2所示,为样品溶液和空白样品溶液在正离子模式下的BPC(Base PeakChromatogram)图谱,图3为负离子模式下的BPC图谱,图4为鱼腥草饮片260~400nm紫外吸收图。从图中可知,该方法共有36种非挥发性次生代谢产物检测出来。The detection method provided in Example 2 (that is, the concentration of methanol solution was 70%, extracted twice) was selected for detection. As shown in Figure 2, it is the BPC (Base Peak Chromatogram) spectrum of the sample solution and blank sample solution in positive ion mode, Figure 3 is the BPC spectrum in negative ion mode, and Figure 4 is the UV absorption map of Houttuynia cordata decoction pieces at 260-400 nm. As can be seen from the figure, a total of 36 non-volatile secondary metabolites were detected by this method.
下面对各成分进行进一步鉴定和含量测定。Further identification and content determination of each component are carried out below.
(1)酚酸类成分鉴定(1) Identification of phenolic acids
选用该检测方法,共鉴定出3个酚酸类成分,分别为化合物1:5-CQA(新绿原酸),化合物2:3-CQA(绿原酸)和化合物3:4-CQA(隐绿原酸)。化合物1、2、3紫外吸收图吸收峰为210nm和325nm;[M+H]+均为m/z 355.10,正离子模式下MS/MS没有差别,如图5所示。负离子模式下[M-H]-均为m/z 353.08(推测分子式为C16H18O9),如图6所示,在MS/MS谱中,化合物1和2的基峰离子m/z 191为奎宁酸碎片,其中化合物1中可见丰度较高的咖啡酸基[M-H-174]-m/z 179的碎片,鉴定为5-CQA(新绿原酸);化合物3的基峰离子[M-H-162-18]-m/z 173为奎宁酸失去H2O产生的,鉴定为4-CQA(隐绿原酸)。化合物2与对照品绿原酸的保留时间及MS/MS碎片一致,故化合物2为3-CQA(绿原酸)。Using this detection method, a total of 3 phenolic acid components were identified, namely compound 1: 5-CQA (neochlorogenic acid), compound 2: 3-CQA (chlorogenic acid) and compound 3: 4-CQA (crypto green ortho acid). The UV absorption peaks of
(2)黄酮类成分鉴定(2) Identification of flavonoids
化合物17在负离子模式下分子离子峰[M-H]-为m/z 301.0353(推测分子式为C15H10O7),其二级质谱图中可观测到RDA裂解得到碎片151.0035。失去一分子CO,形成m/z273.0411离子。MS/MS图谱中还有一个显著的碎片m/z 178.9982(C8H3O5 -),此碎片丢失分子量为27.9949Da的碎片(CO)后形成的。此外还有槲皮素在负离子模式下经典碎片如图7所示,鉴定化合物17为槲皮素。槲皮素的裂解规律如下:The molecular ion peak [MH] - of compound 17 in negative ion mode is m/z 301.0353 (presumably the molecular formula is C 15 H 10 O 7 ), and fragment 151.0035 can be obtained by RDA fragmentation in its MS spectrum. One molecule of CO is lost to form the m/z 273.0411 ion. There is also a prominent fragment m/z 178.9982 (C 8 H 3 O 5 - ) in the MS/MS spectrum, which was formed after the loss of the fragment (CO) with a molecular weight of 27.9949 Da. In addition, the classical fragment of quercetin in negative ion mode is shown in Figure 7, and compound 17 was identified as quercetin. The cleavage rule of quercetin is as follows:
化合物10负离子模式下分子离子峰[M-H]-为m/z 609.1461(C27H30O16),在其二级质谱图中,由母离子裂解丢失一分子芸香糖基产生了苷元自由基离子[M-H-309]–m/z 300和苷元离子[M-H-308]–m/z 301。很明显的看到,在二级裂解图谱中,苷元自由基离子m/z300的相对丰度要高于苷元离子m/z 301的相对丰度,如图8所示,表明化合物10结构中的芸香糖基团连接在槲皮素的C-3位,故鉴定为Rutin。The molecular ion peak [MH] of
化合物11和15负离子模式下分子离子峰[M-H]-均为m/z 431.0987(C21H20O10),在化合物15的MS/MS图谱中可见失去鼠李糖基(146Da)的[Y0-H]-m/z 284,相对丰度高于苷元离子[Y0]-,如图8所示,鉴定化合物15为Afzelin。化合物11的MS/MS图谱中得到基峰[M-H-120]-m/z 311,碎片峰[M-H-90]-m/z341,[M-H-120-CO]-m/z 283,此裂解途径与Vitexin/Isovitexin的裂解途径一致,如图8所示,鉴定化合物11为Vitexin/Isovitexin。The molecular ion peaks [MH] of compounds 11 and 15 in negative ion mode are both m/z 431.0987 (C 21 H 20 O 10 ), and in the MS/MS spectrum of
化合物13负离子模式下分子离子峰[M-H]-为m/z 447.0940(C21H20O11),MS/MS图谱中可见失去鼠李糖基(146Da)的m/z 301相对丰度高于m/z 300,表明该化合物为7-O-黄酮苷,推测为Quercitrin。The molecular ion peak [MH] of
化合物12和12’负离子模式下分子离子峰[M-H]-均为m/z 463.0886(C21H20O12)均产生了苷元自由基离子[M-H-163]–m/z 300和苷元离子[M-H-162]–m/z 301,且苷元自由基离子m/z 300的相对丰度要高于苷元离子m/z301的相对丰度,表明化合物12和12’均为3-O-黄酮苷。通过对比对照品Hyperoside的出峰时间(如图9)确定化合物12为Hyperoside,另化合物12’为Isoquercitrin。Compounds 12 and 12' in negative ion mode have molecular ion peaks [MH] - both at m/z 463.0886 (C 21 H 20 O 12 ) both produce aglycon radical ions [MH-163] - m/
(3)生物碱类成分鉴定(3) Identification of alkaloids
实施例2提供的检测方法在鱼腥草破壁饮片中鉴定出Aporphines类化合物,属首次在该药材中发现。The detection method provided in Example 2 identifies aporphines in the broken wall decoction pieces of Houttuynia cordata, which is the first time found in this medicinal material.
将鱼腥草中生物碱分为3类:The alkaloids in Houttuynia cordata are divided into 3 categories:
(1)Amides类,如化合物16(Moupinamide)和24(Asperglaucide);(1) Amides, such as compounds 16 (Moupinamide) and 24 (Asperglaucide);
(2)Aristolactams类,主要包括化合物23(Cepharanone B)、19(Caldensin)、20(AristolactamAII)、20’(PiperolactamA);(2) Aristolactams, mainly including compounds 23 (Cepharanone B), 19 (Caldensin), 20 (AristolactamAII), 20' (PiperolactamA);
(3)Aporphine类,其中又可分为3小类:(3) Aporphine category, which can be divided into 3 subcategories:
①Oxoaporphines类,主要包括化合物21(Splendidine)、18(Lysicamine)、14(4-hydroxy-1,2,3-trimethoxy-7H-dibenzo-quinolin-7-one);①Oxoaporphines, mainly including compounds 21(Splendidine), 18(Lysicamine), 14(4-hydroxy-1,2,3-trimethoxy-7H-dibenzo-quinolin-7-one);
②5,4-Dioxoaporphines类,主要有化合物19(Noraritolodione)、21’(Cepharadione B)、22(Norcepharadione B)、14’(Ouregidione);②5,4-Dioxoaporphines, mainly including compounds 19 (Noraritolodione), 21' (Cepharadione B), 22 (Norcepharadione B), 14' (Ouregidione);
③Aporphines类,主要有化合物4(4a、4a’、4b、4b’),5、5’,6、6’,7(7a、7b、7c)和化合物9(Asimilobine),具体如图10。③Aporphines, mainly include compounds 4 (4a, 4a', 4b, 4b'), 5, 5', 6, 6', 7 (7a, 7b, 7c) and compound 9 (Asimilobine), as shown in Figure 10.
(3.1)Amides类(3.1) Amides class
对照品Moupinamide正离子模式下[M+H]+m/z 314.1408,对照品及鱼腥草饮片中化合物16,24的MS/MS图谱如图11所示。The reference substance Moupinamide is [M+H] + m/z 314.1408 in positive ion mode, and the MS/MS spectra of
(3.2)Aristolactams类(3.2) Aristolactams class
根据文献鱼腥草中马兜铃内酰胺类生物碱有AristolactamA I、PiperolactamA、Cepharanone B和Caldensin,4个成分二级质谱裂解图谱如图12所示。According to the literature, the aristololactam alkaloids in Houttuynia cordata include AristolactamA I, PiperolactamA, Cepharanone B and Caldensin.
(3.3)Aporphine类(3.3) Aporphine class
根据参考文献,阿朴菲类生物碱ESI-MSn裂解规律为首先丢失RNH2,当6位N无取代时丢失NH3(17Da)产生[M+H-17]+碎片,当6位N有甲基取代时丢失CH3NH2(31Da)产生[M+H-31]+碎片。随后,在含有邻位羟基和甲氧基的生物碱中丢失CH3OH,随后丢失CO。阿朴菲类生物碱结构式及裂解规律如下所示:According to the reference, the cleavage rule of ESI-MS n of apophenanthine alkaloids is that RNH 2 is lost first, and NH 3 (17Da) is lost when the 6-position N is unsubstituted to produce [M+H-17] + fragments, and when the 6-position N is unsubstituted, the [M+H-17] + fragment is generated. Loss of CH3NH2 ( 31 Da) with methyl substitution yields the [M+H-31] + fragment. Subsequently, CH 3 OH is lost in alkaloids containing vicinal hydroxyl and methoxy groups, followed by loss of CO. The structural formulas and cracking rules of apophthene alkaloids are as follows:
化合物9正离子模式下[M+H]+m/z为268.1333,MS/MS图谱如图13所示。The [M+H] + m/z of compound 9 in positive ion mode is 268.1333, and the MS/MS spectrum is shown in Figure 13 .
推测其裂解碎片及途径如下所示It is speculated that its fragmentation fragments and pathways are as follows
符合Aporphine类化合物在正离子模式下裂解规律,对比Massbank网站中Asimilobine的ESI-MS2图谱(如图14),合理推测该化合物为Asimilobine。Consistent with the fragmentation rule of aporphine compounds in positive ion mode, and comparing the ESI-MS 2 spectrum of Asimilobine in the Massbank website (as shown in Figure 14), it is reasonable to speculate that the compound is Asimilobine.
含有一个或多个不与羟基相邻的甲氧基取代的啊朴啡类生物碱在二级质谱中往往先有15Da(CH3*)或31Da(OCH3*)偶极损耗。该规律的裂解碎片在含有邻位羟基和甲氧基的阿朴啡类生物碱中也可观察到,只是丰度很低。化合物7c先丢失17Da说明N无取代,且无丢失32Da(CH3OH)碎片,推测1位和11位没有同时存在羟基和亚甲基,故推测化合物7C为Laurotetanine。依此规律推测出一系列类似成分如4a,4b,5,5’,6,6’,7a,7b等化合物。Arborphine alkaloids containing one or more methoxy groups that are not adjacent to the hydroxyl group often have a dipole loss of 15Da(CH3*) or 31Da(OCH3*) in the secondary mass spectrometry. This regular fragmentation was also observed in apophine alkaloids containing vicinal hydroxyl and methoxy groups, but in very low abundance. Compound 7c lost 17Da first, indicating that N was not substituted, and there was no loss of 32Da(CH 3 OH) fragment. It was speculated that there was no hydroxyl group and methylene group at the 1-position and 11-position, so compound 7C was speculated to be Laurotetanine. According to this rule, a series of similar components such as 4a, 4b, 5, 5', 6, 6', 7a, 7b and other compounds are deduced.
(3.4)Megastigmane Glycosides类(3.4) Megastigmane Glycosides
化合物8在负离子模式下分子离子峰[M-H]-为m/z 385.1866(C19H30O8),产生丢失葡萄糖基(162Da)的碎片m/z 223,该化合物为Megastigmane Glycosides类成分,并结合参考文献推测化合物8为The molecular ion peak [MH] of
(E)-4-Hydroxy-4-[3’-(β-D-glucopyranosyloxy)butylidene]-3,5,5-trimethyl-2-cyclophexen-1-one。(E)-4-Hydroxy-4-[3'-(β-D-glucopyranosyloxy)butylidene]-3,5,5-trimethyl-2-cyclophexen-1-one.
2.2非挥发类次生代谢产物鉴定及含量测定结果2.2 Identification and content determination results of non-volatile secondary metabolites
根据上述化学成分质谱裂解规律及MS提供的精确分子量鉴定出鱼腥草饮片中非挥发类次生代谢产物,各化学成分及其含量检测结果如表4所示。The non-volatile secondary metabolites in Houttuynia cordata decoction pieces were identified according to the above-mentioned chemical composition mass spectrometry fragmentation rules and the accurate molecular weight provided by MS. The detection results of each chemical composition and its content are shown in Table 4.
表4鱼腥草破壁饮片各化学成分指认结果Table 4 Identification results of chemical components of Houttuynia cordata decoction pieces
表56批鱼腥草饮片中各成分含量测定结果Table 56 batches of Houttuynia cordata decoction pieces content determination results
注:标*的是根据对照品测得的绝对含量,没有标记的为相对含量;标a的马兜铃内酰胺类生物碱以马兜铃内酰胺I为对照品计算含量,标b的Aporphine类生物碱以大麻酰胺(CannabisinA)为对照品计算含量。Note: The absolute content measured according to the reference substance is marked with *, and the relative content is not marked; the content of aristololactam alkaloids marked with aristolochia lactam I is calculated as the reference substance, and the content of Aporphine marked with b The content of alkaloids was calculated with Cannabisin A as the reference substance.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited by the above-mentioned embodiments, and any other changes, modifications, substitutions, combinations, The simplification should be equivalent replacement manners, which are all included in the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711205106.5A CN108037197B (en) | 2017-11-27 | 2017-11-27 | A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711205106.5A CN108037197B (en) | 2017-11-27 | 2017-11-27 | A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108037197A CN108037197A (en) | 2018-05-15 |
CN108037197B true CN108037197B (en) | 2020-08-07 |
Family
ID=62093224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711205106.5A Active CN108037197B (en) | 2017-11-27 | 2017-11-27 | A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108037197B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112014480B (en) * | 2019-05-28 | 2023-03-28 | 黄河科技学院 | Method for detecting content of effective components in Jiangzhining granules by UPLC-MS/MS |
CN110927312A (en) * | 2019-12-03 | 2020-03-27 | 广东一方制药有限公司 | A kind of construction method of UPLC characteristic map of Meihua formula granule and its component content determination method |
CN112362771B (en) * | 2020-10-29 | 2021-08-20 | 上海鹿明生物科技有限公司 | Method for high-throughput analysis of plant secondary metabolites based on LCMS and application |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100720151B1 (en) * | 2005-12-13 | 2007-05-18 | 한국생명공학연구원 | Flavonoid Compounds Having Antiviral Activity |
CN102809617B (en) * | 2012-08-21 | 2014-07-02 | 浙江国镜药业有限公司 | Herba houttuyniae aboveground part extract and detection method thereof |
CN104849363A (en) * | 2015-03-17 | 2015-08-19 | 中山市中智药业集团有限公司 | Fingerprint construction and quality detection method of broken wall decoction pieces of Houttuynia cordata |
CN107271577B (en) * | 2016-04-08 | 2020-10-30 | 天士力医药集团股份有限公司 | Method for analyzing effective components of Qiling kidney-warming and bursa-eliminating preparation |
CN107132291B (en) * | 2017-05-22 | 2020-05-19 | 河北中医学院 | A Quantitative Method for Determination of 10 Components in Evodia Fructus Formula Granules by UPLC-MS |
CN107860848A (en) * | 2017-11-15 | 2018-03-30 | 成都中医药大学 | A kind of HPLC methods for detecting cordate houttuynia flavones ingredient content |
-
2017
- 2017-11-27 CN CN201711205106.5A patent/CN108037197B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108037197A (en) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhuang et al. | Chemical profiling and quantitation of bioactive compounds in Platycladi Cacumen by UPLC-Q-TOF-MS/MS and UPLC-DAD | |
Negri et al. | Saponins, tannins and flavonols found in hydroethanolic extract from Periandra dulcis roots | |
CN108037197B (en) | A method for qualitative and quantitative analysis of chemical constituents of non-volatile secondary metabolites in Houttuynia cordata decoction pieces | |
Liang et al. | Rapid classification and identification of chemical components of Astragali radix by UPLC‐Q‐TOF‐MS | |
CN104359968B (en) | Realize to the Fast Classification of chemical composition in Ixeris Sonchifolia Hance injection and qualification based on UPLC-Q-TOF-MS technology | |
Liu et al. | Structural characterization and screening of chemical markers of flavonoids in Lysimachiae Herba and Desmodii Styracifolii Herba by ultra high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry based metabolomics approach | |
CN114184727B (en) | Identification method and application of three medicinal materials derived from saponins | |
Liu et al. | Comprehensive phytochemical analysis and sedative-hypnotic activity of two Acanthopanax species leaves | |
Wang et al. | Characterization of chemical profile and quantification of major representative components of Wendan decoction, a classical traditional Chinese medicine formula | |
Liu et al. | Identification and analysis of cardiac glycosides in Loranthaceae parasites Taxillus chinensis (DC.) Danser and Scurrula parasitica Linn. and their host Nerium indicum Mill. | |
Yang et al. | Phytochemical Analysis, Anti‐inflammatory, and Antioxidant Activities of Dendropanax dentiger Roots | |
Ishak et al. | Mitragynine: a review of its extraction, identification, and purification methods | |
Yu et al. | Application of characteristic fragment filtering with ultra high performance liquid chromatography coupled with high‐resolution mass spectrometry for comprehensive identification of components in Schisandrae chinensis fructus | |
Su et al. | Two Species Origins Comparison of Herba Patriniae Based on Their Ingredients Profile by UPLC‐QTOF/MS/MS and Orthogonal Partial Least Squares Discriminant Analysis | |
Zhang et al. | Analysis of the chemical components of Qixianqingming granules and their metabolites in rats by UPLC‐ESI‐Q‐TOF‐MS | |
CN101215313B (en) | Mixture of Steroidal Saponins from Aegypti officinalis Carbon-21 with Anti-tumor Effect | |
CN112305141B (en) | Method for constructing ginsenoside virtual database and method for identifying ginsenoside | |
Zheng et al. | Identification of Chemical Constituents in Zhizhu Pills Based on UPLC-QTOF-MSE | |
Dou et al. | Rapid classification and identification of chemical constituents in Leonurus japonicus Houtt based on UPLC‐Q‐Orbitrap‐MS combined with data post‐processing techniques | |
CN115639285B (en) | A method for analyzing the chemical components and content determination of Chlorophytum comosum based on liquid chromatography-quadrupole-orbital trap tandem mass spectrometry | |
Rong-Rong et al. | Rapid screening and identification of sesquiterpene lactones in Kudiezi injection based on high-performance liquid chromatography coupled with linear ion trap-orbitrap mass spectrometry | |
He et al. | Structural characterization of chemical compounds based on their fragmentation rules in Sophorae Fructus by UPLC-QTOF-MS/MS | |
Gao et al. | Profiling and characterization of the constituents of taibai ginseng using ultra‐high performance liquid chromatography‐quadrupole time of flight mass spectrometry | |
CN114924007A (en) | UPLC-Q-TOFMS detection method for rapidly identifying various flavonoid compounds in blood ginseng | |
Liu et al. | Analysis of chemical constituents of Sabia parviflora by ultrahigh performance liquid chromatography quadrupole time of flight tandem mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |